Mimedx (MDXG) EBIT Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.47% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -12.10% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 55.96% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -261.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -261.40% |
| Dec 31, 2025 | 23.06% |
| Sep 30, 2025 | 72.40% |
| Jun 30, 2025 | 48.64% |
| Mar 31, 2025 | 42.39% |
| Dec 31, 2024 | 104.90% |
| Sep 30, 2024 | 131.35% |
| Jun 30, 2024 | 289.73% |
| Mar 31, 2024 | 57.76% |
| Dec 31, 2023 | 43.62% |
| Sep 30, 2023 | 46.53% |
| Jun 30, 2023 | 56.74% |
| Mar 31, 2023 | 70.86% |
| Dec 31, 2022 | 62.89% |
| Sep 30, 2022 | -35.73% |
| Jun 30, 2022 | 17.36% |
| Mar 31, 2022 | 11.49% |
| Dec 31, 2021 | 28.94% |
| Sep 30, 2021 | -69.64% |
| Jun 30, 2021 | -30.94% |
| Mar 31, 2021 | -62.69% |
| Dec 31, 2020 | -38.75% |
| Sep 30, 2020 | -45.78% |
| Jun 30, 2020 | -41.14% |
| Mar 31, 2020 | -61.63% |
| Dec 31, 2019 | 18.03% |
| Sep 30, 2019 | 44.53% |
| Jun 30, 2019 | -89.40% |
| Mar 31, 2019 | -123.36% |
| Dec 31, 2018 | -46.65% |
| Sep 30, 2018 | -61.84% |
| Jun 30, 2018 | -33.33% |
| Mar 31, 2018 | -11.23% |
| Dec 31, 2017 | 72.75% |
| Sep 30, 2017 | 33.32% |
| Jun 30, 2017 | 173.24% |
| Mar 31, 2017 | 107.56% |
| Dec 31, 2016 | -84.35% |
| Sep 30, 2016 | 173.15% |
| Jun 30, 2016 | 89.31% |
| Mar 31, 2016 | 103.81% |
| Dec 31, 2015 | 115.24% |
| Sep 30, 2015 | 56.69% |
| Jun 30, 2015 | 268.64% |
| Mar 31, 2015 | 105.88% |
| Dec 31, 2014 | 57.54% |
| Sep 30, 2014 | 62.08% |
| Jun 30, 2014 | 45.46% |
| Mar 31, 2014 | 35.08% |